Following recent news reports that the NHS is likely to miss its MRSA and Clostridium difficile reduction targets, UV disinfection specialist Hanovia has introduced a new range of portable air purifiers.
The manufacturer claims that the purifiers are ideal for localised protection in areas such as intensive care units, isolation wards (positive and negative pressure), clean rooms and laboratories. They can also be used for more general air treatment in hospitals wards, outpatient areas, waiting rooms and offices.
The devices utilise a combination of multi-level filtration, including a 99.97%, 0.3 µm HEPA filter, and UV disinfection. The filters remove virtually all microorganisms as well as VOCs (volatile organic compounds), odours, chemicals, pollen and other small particles. The four lamp UV-C disinfection system provides an extra level of protection, killing any remaining microorganisms not caught by the filters.
Recent clinical trials in hospitals in France and Canada have proved the effectiveness of the NQ and NQ 500 in reducing airborne infections. The French trials concluded the both the NQ and NQ 500 demonstrated high efficacy at totally removing the airborne spore TCS within a very short period of time in a “non-sealed” hospital bedroom.
